Activating fusions of NTRK1, NTRK2, or NTRK3 occur in approximately 40% of pediatric high-grade gliomas and NTRK2 fusions in about 3% of pediatric pilocytic astrocytomas [63,87,88]. The gene discussed is NTRK3; the disease is malignant glioma.